Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Voyager Therapeutics, Inc. - Common Stock (NQ: VYGR )

4.220 -0.040 (-0.94%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 282,622
Open 4.290
Bid (Size) 4.230 (2)
Ask (Size) 4.320 (1)
Prev. Close 4.260
Today's Range 4.205 - 4.354
52wk Range 4.001 - 10.66
Shares Outstanding 54,625,586
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
VYGR Investors Have Opportunity to Join Voyager Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
A Glimpse Into The Expert Outlook On Voyager Therapeutics Through 5 Analysts
Via Benzinga

Performance

YTD
-29.31%
-29.31%
1 Month
-22.28%
-22.28%
3 Month
-25.38%
-25.38%
6 Month
-37.94%
-37.94%
1 Year
-45.27%
-45.27%

More News

Read More
Voyager Therapeutics Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
Via Benzinga
Earnings Scheduled For November 12, 2024
Via Benzinga
Preview: Voyager Therapeutics's Earnings
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
In-Depth Examination Of 4 Analyst Recommendations For Voyager Therapeutics
Via Benzinga
What Analysts Are Saying About Voyager Therapeutics Stock
Via Benzinga
Is VOYAGER THERAPEUTICS INC (NASDAQ:VYGR) suited for growth investing?
Via Chartmill
Get “Picky” With Stocks For September Profits
Via Talk Markets
3 High-Growth Stocks Poised To Double By Next Year
Via Talk Markets
7 Biotech Stocks to Buy for Their Game-Changing Potential
Via InvestorPlace
VYGR Stock Earnings: Voyager Therapeutics Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
VYGR Stock Earnings: Voyager Therapeutics Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
The Healthcare Bargain Blitz: 7 Undervalued Stocks to Inject into Your Portfolio
Via InvestorPlace
Is NASDAQ:VYGR a Fit for Growth Investing Strategies?
Via Chartmill
Delving into NASDAQ:VYGR's Growth Prospects.
Via Chartmill
Cheap Thrills: 7 Promising Value Stocks You Can Buy for Under $20
Via InvestorPlace
Analyst Bullish On Gene Therapy-Focused Voyager Therapeutics Sees Best In Class Potential For Its Neurogenetic Medicine Platform
Via Benzinga
Exploring NASDAQ:VYGR's growth characteristics.
Via Chartmill
Is VOYAGER THERAPEUTICS INC (NASDAQ:VYGR) suited for growth investing?
Via Chartmill
Tech Stocks Set To Rise Thursday As January Inflation Data Fails To Scare Markets, Small Caps Surge
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Why Okta Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.